SCHEMBL3837288

SCHEMBL3837288

COCCCNCCOc1ccc(C(F)(F)F)cc1NC(=O)Nc1ccc(-n2ccc(=O)c3c(N)ncnc32)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
RET P07949 2/20 0.44
KDR P35968 6/20 0.41
RAF1 P04049 4/20 0.41
KDM4E B2RXH2 3/20 0.41
HTT P42858 2/20 0.41
KMT2A Q03164 1/20 0.41
BRAF P15056 1/20 0.41
FLT1 P17948 6/20 0.41
TEK Q02763 5/20 0.41
CSF1R P07333 3/20 0.41
KIT P10721 3/20 0.41
FLT4 P35916 3/20 0.41
AURKA O14965 3/20 0.41
PDGFRB P09619 3/20 0.41
LCK P06239 2/20 0.41
FGFR1 P11362 2/20 0.41
PDGFRA P16234 2/20 0.41
FGFR3 P22607 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3829906 0.91 RET (0.47) RETKDRRAF1KDM4EHTT
SCHEMBL3834620 0.90 RET (0.39) RETKDRRAF1BRAFFLT1
SCHEMBL3239039 0.90 RET (0.40) RETKDRRAF1BRAFFLT1
SCHEMBL3837284 0.89 RET (0.44) ALDH1A1SMN1; SMN2RETKDRRAF1
SCHEMBL3829680 0.87 RET (0.50) RETKDRRAF1KDM4EBRAF
SCHEMBL3235249 0.84 KDR (0.37) RETKDRRAF1BRAFFLT3
SCHEMBL3836301 0.83 KDR (0.54) KDRRAF1BRAFFLT3
SCHEMBL3834284 0.81 RET (0.43) RETKDRRAF1BRAFFLT1
SCHEMBL3831528 0.81 RET (0.61) RETKDRFLT1TEKCSF1R
SCHEMBL13790976 0.81 KDM4E (0.42) ALDH1A1SMN1; SMN2KDRRAF1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1682548-B1 PYRIDOPYRIMIDINONES FOR THE TREATMENT OF CANCER DISEASES MERCK PATENT GMBH (DE) 2009-09-23 EP claimed